Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Urethra”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02665039
What this trial is testing

A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function

Who this might be right for
Urothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more
Dr Anders Ullén 62
Not applicableEnded earlyNCT06069453
What this trial is testing

Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Fidia Farmaceutici s.p.a. 54
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Early research (Phase 1)Active Not RecruitingNCT02496208
What this trial is testing

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Who this might be right for
Bladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more
National Cancer Institute (NCI) 152
Large-scale testing (Phase 3)Study completedNCT00022191
What this trial is testing

Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 608
Testing effectiveness (Phase 2)Study completedNCT01282463
What this trial is testing

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

Who this might be right for
Carcinoma of Urinary TractUrethral CarcinomaCarcinoma of Ureter+1 more
Eli Lilly and Company 148
Large-scale testing (Phase 3)Study completedNCT00003701
What this trial is testing

Combination Chemotherapy in Treating Patients With Bladder Cancer

Who this might be right for
Bladder CancerUrethral Cancer
Eastern Cooperative Oncology Group 490
Testing effectiveness (Phase 2)Ended earlyNCT01126749
What this trial is testing

Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer

Who this might be right for
Bladder Cancer
Eisai Inc. 92
Not applicableStudy completedNCT04924218
What this trial is testing

Evaluation of the Effect of Endoscopic Urethral Procedures Applied After Radical Prostatectomy on Urinary Incontinence

Who this might be right for
Prostate CancerIncontinence
Ankara Yildirim Beyazıt University 18
Testing effectiveness (Phase 2)Study completedNCT00397488
What this trial is testing

Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Ended earlyNCT00112905
What this trial is testing

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Who this might be right for
Adenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more
National Cancer Institute (NCI) 27
Not applicableStudy completedNCT02761889
What this trial is testing

Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Fundacao Champalimaud 444
Not applicableStudy completedNCT02643043
What this trial is testing

UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch

Who this might be right for
Urothelial CarcinomaBladder CancerUrethral Cancer+1 more
Matthew Milowsky, MD 219
Not applicableStudy completedNCT02812173
What this trial is testing

Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP

Who this might be right for
Prostate Cancer
St. Antonius Hospital Gronau 234
Not applicableStudy completedNCT04804839
What this trial is testing

Comparison of the Effectiveness of Different Conservative Treatment Protocols in Postprostatectomy Urinary Incontinence

Who this might be right for
Urinary IncontinenceProstate CancerUrinary Incontinence,Stress+1 more
Hacettepe University 72
Not applicableActive Not RecruitingNCT03291028
What this trial is testing

Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaBladder Cancer+2 more
Fox Chase Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00252941
What this trial is testing

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

Who this might be right for
Prostate CancerPost-Brachytherapy Bladder Outlet Obstruction
The Cleveland Clinic 20
Early research (Phase 1)Study completedNCT01844947
What this trial is testing

Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

Who this might be right for
Urothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more
Dr Anders Ullén 22
Testing effectiveness (Phase 2)Study completedNCT00002684
What this trial is testing

Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer

Who this might be right for
Bladder CancerUrethral Cancer
Memorial Sloan Kettering Cancer Center 40
Not applicableLooking for participantsNCT07694752
What this trial is testing

MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base Morphology

Who this might be right for
Urethral Internal Sphincter MorphologyBenign Prostatic HyperplasiaProstate Cancer
Jiangsu Taizhou People's Hospital 80
Next Page